These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8293182)
1. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Newcomb EW; Madonia WJ; Pisharody S; Lang FF; Koslow M; Miller DC Brain Pathol; 1993 Jul; 3(3):229-35. PubMed ID: 8293182 [TBL] [Abstract][Full Text] [Related]
2. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of p53 gene and protein alterations in human astrocytic tumors. Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161 [TBL] [Abstract][Full Text] [Related]
5. p53 mutation and epidermal growth factor receptor overexpression in glioblastoma. Yoon KS; Lee MC; Kang SS; Kim JH; Jung S; Kim YJ; Lee JH; Ahn KY; Lee JS; Cheon JY J Korean Med Sci; 2001 Aug; 16(4):481-8. PubMed ID: 11511795 [TBL] [Abstract][Full Text] [Related]
7. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097 [TBL] [Abstract][Full Text] [Related]
8. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. Lang FF; Miller DC; Koslow M; Newcomb EW J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151 [TBL] [Abstract][Full Text] [Related]
9. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry. Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954 [TBL] [Abstract][Full Text] [Related]
10. Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Szybka M; Zawlik I; Kulczycka D; Golanska E; Jesien E; Kupnicka D; Stawski R; Piaskowski S; Bieniek E; Zakrzewska M; Kordek R; Liberski PP; Rieske P Br J Cancer; 2008 Apr; 98(8):1431-3. PubMed ID: 18349850 [TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. Biernat W; Kleihues P; Yonekawa Y; Ohgaki H J Neuropathol Exp Neurol; 1997 Feb; 56(2):180-5. PubMed ID: 9034372 [TBL] [Abstract][Full Text] [Related]
12. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Matsushima AY; Cesarman E; Chadburn A; Knowles DM Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043 [TBL] [Abstract][Full Text] [Related]
13. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations. Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620 [TBL] [Abstract][Full Text] [Related]
14. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors. Cheng Y; Ng HK; Ding M; Zhang SF; Pang JC; Lo KW J Neuropathol Exp Neurol; 1999 Feb; 58(2):120-8. PubMed ID: 10029095 [TBL] [Abstract][Full Text] [Related]
16. Ethnicity delineates different genetic pathways in malignant glioma. Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811 [TBL] [Abstract][Full Text] [Related]
17. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway. Das A; Tan WL; Teo J; Smith DR J Neurooncol; 2002 Nov; 60(2):117-25. PubMed ID: 12635658 [TBL] [Abstract][Full Text] [Related]
18. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas. Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540 [TBL] [Abstract][Full Text] [Related]
20. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]